Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001178913-20-000964
Filing Date
2020-03-30
Accepted
2020-03-30 14:39:46
Documents
46
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K zk2024215.htm 10-K 688506
2 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 9093
3 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 4551
  Complete submission text file 0001178913-20-000964.txt   2648196

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT atms-20191231.xml EX-101.INS 502480
5 XBRL TAXONOMY EXTENSION SCHEMA atms-20191231.xsd EX-101.SCH 27759
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atms-20191231_cal.xml EX-101.CAL 26342
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atms-20191231_def.xml EX-101.DEF 77712
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE atms-20191231_lab.xml EX-101.LAB 179957
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atms-20191231_pre.xml EX-101.PRE 140482
Mailing Address 18 EAST 16TH STREET NEW YORK NY 10003
Business Address 18 EAST 16TH STREET NEW YORK NY 10003 646-233-1454
Artemis Therapeutics, Inc. (Filer) CIK: 0001062128 (see all company filings)

EIN.: 841417774 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24431 | Film No.: 20756241
SIC: 2890 Miscellaneous Chemical Products